Characteristics and conflicts of interest at Food and Drug Administration Gastrointestinal Drug Advisory Committee meetings.
<h4>Introduction</h4>The United States Food and Drug Administration (FDA) Gastrointestinal Drug Advisory Committee (GIDAC) is involved in gastrointestinal drug application reviews. Characteristics and conflicts of interest (COI) in GIDAC meetings are not well described. This study analyz...
Saved in:
Main Authors: | Rishad Khan, Karam Elsolh, Nikko Gimpaya, Michael A Scaffidi, Rishi Bansal, Samir C Grover |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f4fba966226b48adb7a4e44f6e42689c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Automated detection of cecal intubation with variable bowel preparation using a deep convolutional neural network
by: Daniel J. Low, et al.
Published: (2021) -
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.
by: Kristin Rising, et al.
Published: (2008) -
Evaluation of an advisory committee as a model for patient engagement
by: Cynthia Kendell, et al.
Published: (2014) -
Meeting of the Advisory Committee of the Caribbean Planners Network (CPN)
Published: (2014) -
Screening and Identification of Lujo Virus Entry Inhibitors From an Food and Drug Administration-Approved Drugs Library
by: Junyuan Cao, et al.
Published: (2021)